$19.31-8.79%
2026-10-06 close · prelimImmunome's published financial data is dated 2026-10-04. 2024 revenue was $9M. 2024 operating profit was −$306M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy
Immunome's published financial data is dated 2026-10-04. 2024 revenue was $9M. 2024 operating profit was −$306M.